TLR9 and systemic lupus erythematosus: Targeting TLR in SLE may be therapeutically advantageous based on the roles of TLR7 and TLR9 in the effector function of B cells in lupus-like disease and SLE patients as well as the distinctive characteristics of TLR signaling in B cells (Fillatreau et al., 2021).